Bristol/Medarex’s Ipilimumab Toxic, But Could Extend Life
This article was originally published in The Pink Sheet Daily
Executive Summary
Melanoma drug’s side effects indicate immune-boosting cancer drug’s effectiveness, investigator tells “The Pink Sheet” DAILY.